News

Radient Pharmaceuticals (Radient) has signed a three-year marketing, sales and distribution agreement with GenWay Biotech. As per the agreement, GenWay Biotech has non-exclusive rights to distribute RPC’s Onko-Sure

Ranbaxy will launch Olmesartan Medoxomil, an antihypertensive originally discovered by Daiichi Sankyo, in six African countries: Kenya, Mozambique, Nigeria, Tanzania, Uganda, and Zambia. The companies will launch the

China Aoxing Pharmaceutical (China Aoxing) has received the Good Manufacturing Practice (GMP) re-certification of four dosage forms, including capsule, tablet, granule and oral solution formulations, at its new

The FDA has granted Emergency Use Authorisation (EUA) to TessArae for its TessArray Resequencing Influenza A Microarray Detection Panel for the detection of the 2009 H1N1 Influenza A

The Society of Chemical Manufacturers and Affiliates (SOCMA) has reported that Larry Brotherton, CEO and owner of Ortec was elected Board of Governors chairman during SOCMA’s Annual Meeting

Isis will receive a $10m payment from OncoGenex Pharmaceuticals as a result of OncoGenex’ license of OGX-011 to Teva. OGX-011 is an antisense drug co-discovered by Isis and

Intra-Cellular Therapies (ITI) has completed phase I clinical study demonstrating ITI-007, the company’s lead antipsychotic drug, interacts with important targets in the living human brain. These key targets

Novartis has announced that the World Health Organization (WHO) has granted prequalification for all three of its influenza A(H1N1) 2009 monovalent vaccines for supply to the UN agencies.

Teva Pharmaceutical (Teva) and OncoGenex Pharmaceuticals (OncoGenex) have entered into a global license and collaboration agreement to develop and commercialise OGX-011, as well as an agreement to purchase